Technology

Join Gareth and Peju for two very important discussions on Intellectual Property in AI and data technologies and Diversity in data for drug discovery and clinical applications.

Alix Lacoste, VP Data Science at BenevolentAI, will discuss the application of machine learning in drug discovery, and explore evaluation models and the issue of data diversity.

Join BenevolentAI Board Director Jackie Hunter at Bayer’s LifeHub UK virtual event for a discussion of machine learning and AI in healthcare, alongside Lionel Tarassenko.

Nathan Brown, Head of Cheminformatics at BenevolentAI, will review the development of de novo design methods over the years including the author’s original work in this area from the early 2000s, to recent approaches that show great promise.